Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arcadia Biosciences, Inc. Director's Dealing 2019

Nov 19, 2019

35424_dirs_2019-11-19_5344b577-04e3-4423-83cd-915bc2ae8466.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2019-11-18

Reporting Person: Murray Lilian Shackelford (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-11-18 Common stock P 5000 $4.25 Acquired 8524 Direct